Maria Beatriz Carreira

Dr. Maria Beatriz Carreira

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

25 September 2020 in medRxiv
Verified
Preprint
Open access
PDF file
AVAlcibiades Elias Villarreal
Alcibiades Elias Villarreal
GRGiselle Rangel
Giselle Rangel
XZXu Zhang
Xu Zhang
DWDigna Wong
Digna Wong
GBGabrielle Britton
Gabrielle Britton
Amador GoodridgeAmador Goodridge
Amador Goodridge
Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has reached 28 million cases worldwide in eight months. The serological detection of antibodies against the virus will play a pivotal role in complementing molecular tests to improve diagnostic accuracy, contact tracing, vaccine efficacy testing and seroprevalence surveillance. Here, we aimed first to evaluate a lateral flow assay’s ability to identify specific IgM and IgG antibodies against SARS-CoV-2 and second, to report the seroprevalence of these antibodies among health care workers and healthy volunteer blood donors in Panama. We recruited study participants between April 30 th and July 7 th , 2020. For the test validation and performance evaluation, we analyzed serum samples from participants with clinical symptoms and confirmed positive RT-PCR for SARS-CoV-2, participants with other confirmed infectious diseases, and a set of pre-pandemic serum samples. We used two by two table analysis to determine the test sensitivity and specificity as well as the kappa agreement value with a 95% confidence interval. Then, we used the lateral flow assay to determine seroprevalence among serum samples from COVID-19 patients, potentially exposed health care workers, and healthy volunteer donors. Our results show this assay reached a positive percent agreement of 97.2% (95% CI 84.2-100.0%) for detecting both IgM and IgG. The assay showed a kappa of 0.898 (95%CI 0.811-0.985) and 0.918 (95% CI 0.839-0.997) for IgM and IgG, respectively. The evaluation of serum samples from hospitalized COVID-19 patients indicates a correlation between test sensitivity and the number of days since symptom onset; the highest positive percent agreement (87% (95% CI 67.0-96.3%)) was observed at ≥15 days post-symptom onset. We found an overall antibody seroprevalence of 11.6% (95% CI 8.5-15.8%) among both health care workers and healthy blood donors. Our findings suggest this lateral flow assay could contribute significantly to implementing seroprevalence testing in locations with active community transmission of SARS-CoV-2.

24 July 2025 in Journal of Alzheimer's Disease Reports
Verified
Journal Article
Open access
GTGiselle Rangel Tapia
Giselle Rangel Tapia
BMBerta A Muñoz
Berta A Muñoz
MRMorgan Ramirez
Morgan Ramirez
KWKristen Wroblewski
Kristen Wroblewski
AVAlcibiades Elias Villarreal
Alcibiades Elias Villarreal
GBGabrielle Britton
Gabrielle Britton
Background: Accumulating evidence implicates infectious pathogens as triggers of immune–inflammatory processes that contribute to neurodegeneration. Inflammation in both the brain and peripheral circulation is recognized as a critical factor in the development and progression of cognitive decline and neurodegenerative disorders, including Alzheimer's disease. Objective: This retrospective case-control study investigated the association between cognitive impairment and presence of serum antibodies to seven pathogens in older adults. Methods: One hundred sixty-five participants aged ≥ 65 years from the Panama Aging Research Initiative Health Disparities (PARI-HD) study were evaluated. Presence of IgG antibodies against Toxoplasma gondii , Herpes Simplex Virus Type 1 (HSV-1), Human Cytomegalovirus (HCMV), Helicobacter pylori, Chlamydia pneumoniae, Treponema pallidum , and Trypanosoma cruzi was measured. Participant demographics, inflammatory biomarkers and cognitive-functional factors were analyzed for associations with single/multiple pathogen-specific antibodies reactivity using multivariable regression models. Results: Only C. pneumoniae seropositivity was significantly different between cognitively unimpaired and impaired groups (p = 0.02) and increasing TNF-α levels were directly associated with C. pneumoniae seropositivity (OR = 2.08, CI 95% 1.0–4.1, p = 0.04). Additionally, cumulative exposure to infectious agents increased the likelihood of cognitive impairment (OR = 1.51, CI 95% 1.01–2.26, p = 0.04) and was associated with slower processing speed as measured by TMT A test (OR = 17.43, CI 95% 2.32–32.53, p = 0.02). Notably, the presence of C. pneumoniae in multiple pathogen interactions further raised the likelihood of cognitive impairment (OR = 4.07, CI 95% 1.24–13.36, p = 0.03). Conclusions: These results enhance our understanding of cognitive impairment in a Hispanic population and underscore the need for further studies on the role of C. pneumoniae and multi-pathogen infection in Alzheimer's disease.

31 December 2021 in Alzheimer's & Dementia
Verified
Journal Article
Open access
PDF file
DODiana Oviedo
Diana Oviedo
AVAlcibiades Elias Villarreal
Alcibiades Elias Villarreal
GTGiselle Rangel Tapia
Giselle Rangel Tapia
MCMaria Beatriz Carreira
Maria Beatriz Carreira
APAmbar R. Perez‐Lao
Ambar R. Perez‐Lao
GBGabrielle Britton
Gabrielle Britton
Background: Studies on blood‐based biomarkers associated with age‐related cognitive impairment are key to improve intervention mechanisms and delay the expression of symptoms. The objective of this study was to assess the relationship between blood‐based biomarkers and mild cognitive impairment (MCI) and AD in a sample of elderly Panamanians enrolled from an outpatient geriatric service.Method: A descriptive, cross‐sectional, observational study was conducted. Participants were 84 Panamanians (controls, n=41; MCI=32; and AD=11). They were assessed with MMSE and Clock Test. Non‐fasting blood samples were collected to genotype for ApoE4 and to determine a blood‐based biomarker profile.Result: CRP levels among AD participants were significantly increased relative to MCI participants (p < 0.05). A2M levels in AD participants were significantly increased compared to normal controls (p < 0.05). SAA levels in AD participants were significantly increased when compared to MCI participants (p < 0.05).Conclusion: These results show that in the AD group CRP, A2M and SAA are significantly increased. The link between MCI and AD and inflammatory markers can produce an accurate tool that can aid in early diagnosis of AD.

26 November 2024 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
AOAdrian L Orjuela
Adrian L Orjuela
MPMarisín Pecchio
Marisín Pecchio
Jessica Nicole Cruz MoraJessica Nicole Cruz Mora
Jessica Nicole Cruz Mora
LELakshmi Sowmya Emani
Lakshmi Sowmya Emani
MCMaria Beatriz Carreira
Maria Beatriz Carreira
JLJohant Lakey-Beitia
Johant Lakey-Beitia
Background: Carotenoids, potent antioxidants in fruits and vegetables, have recently garnered attention for their potential therapeutic effects against neurodegenerative diseases. This study focuses on the interaction and anti-aggregation properties of conventional and unconventional carotenoids found in red mamey fruit, a nutraceutical fruit that is a rich source of these compounds. Objective: To assess computational the interaction between of amyloid-β (Aβ) peptide with a set of carotenoids and three carotenoids previously explored in experimental assays as well as to assess ADMET prediction of carotenoids selected by computational analysis results. Methods: We analyzed the interaction between these carotenoids and Aβ peptides using molecular docking, a key factor in Alzheimer's disease (AD) pathology. Selected carotenoids were compared with the reference compounds cryptocapsin ( 1 ), zeaxanthin ( 2 ), lutein ( 3 ), and cryptocapsin-5,6-epoxide ( 24 ), which previously demonstrated significant anti-aggregation activity against Aβ. Using SwissADME and ADMET Predictor ® software to determine the pharmaceutical analysis prediction. Results: Computational analysis identified (5R,8R)-sapotexanthin-5,8-epoxide ( 19 ) and (5S,8S)-cryptocapsin-5,8-epoxide ( 26 ) as the most promising candidates due to their strong binding affinity and potential anti-aggregation properties against Aβ. The pharmaceutical analysis identified compounds (5S,8S)-cryptocapsin-5,8-epoxide ( 26 ) and (5R,8R)-cryptocapsin-5,8-epoxide ( 28 ) as the most promising compounds. Our findings suggest that specific modifications in the carotenoid structure, particularly modifications in the type of epoxidation and stereochemistry, can significantly influence the biological activity of carotenoids and biopharmaceutical performance. Conclusions: These results provide valuable insights for future in vitro studies of most potential carotenoids (19 and 26) and the development of potential therapeutic agents for AD.

1 January 2025 in Scientia
Verified
Journal Article
Open access
PDF file
LTLorena Lineth Adames Torres
Lorena Lineth Adames Torres
ALAlanna S. Madrid L
Alanna S. Madrid L
KAKevin Gabriel Mata Arauz
Kevin Gabriel Mata Arauz
JFJulio A. Flores-Cuadra
Julio A. Flores-Cuadra
GBGabrielle Britton
Gabrielle Britton
MCMaria Beatriz Carreira
Maria Beatriz Carreira
La acumulación irregular de la proteína ?-amiloide (A?), la proteína tau hiperfosforilada y la neuroinflamación son factores que afectan la función neuronal en la Enfermedad de Alzheimer (EA). La neuroinflamación asociada a la EA podría causar el daño sináptico por sí mismo o exacerbar el daño causado por la acumulación de A?. Se ha detectado un aumento de la citocina CCL1 (I-309) en el suero de sangre periférica de personas con Deterioro Cognitivo Leve (DCL) y con la EA, por lo que se propone que puede ser útil como un biomarcador diagnóstico del DCL y la EA. El objetivo general de este estudio fue evaluar el efecto de la sobreexpresión de la proteína CCL1 (I-309) en las espinas dendríticas de las neuronas localizadas en el hipocampo. Se utilizó ratas Sprague Dawley (N=6) como modelo animal, a quienes se les realizó cirugías estereotáxicas para inocular la sobreexpresión de CCL1. Se realizó la tinción de Golgi a los cerebros de las ratas, se utilizó un criostato para realizar los cortes histológicos y se evaluó la densidad de las espinas dendríticas mediante microscopia óptica. El ANOVA de una vía no mostró diferencias significativas (p>0.05) entre el grupo con sobreexpresión de CCL1 al compararlo con el grupo control y con el grupo con sobreexpresión A?1-42+CCL1. Se concluyó que la sobreexpresión de CCL1 no modifica significativamente la densidad de espinas dendríticas en el hipocampo.